Xenetic biosciences, inc. (XBIO)

CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Nov'13Aug'13May'13Feb'13Nov'12Aug'12May'12Feb'12Nov'11
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-12,627

-12,775

-13,244

-6,156

-6,805

-7,300

-1,215

-1,659

-2,552

-3,595

-8,431

-8,647

-53,500

-54,206

0

0

0

-

-

-11,041

-12,675

-14,307

-10,086

-6,980

-4,235

-157

-89

-15

-41

-85

-89

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

3

4

6

6

11

15

16

21

21

23

28

32

35

36

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Amortization of right of use asset

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of property and equipment

0

2

2

17

17

15

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

Amortization of hybrid debt instrument discount

-

-

-

-

-

-

-

-

-

-

-

-

-

544

576

312

248

108

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

174

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Share-based expense

755

806

922

995

1,194

1,362

1,394

1,375

1,517

1,784

1,916

2,355

2,094

1,922

1,843

2,848

2,532

2,201

2,710

1,225

1,271

1,513

0

0

0

-

-

-

-

-

-

-

-

-

Warrant-based income (expense) for services

-

-

-

-

-

-

-

-

-106

-126

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant expense for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,959

683

933

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Vendor share-based expense

0

-

-

-

0

-

-

-

121

135

278

133

154

180

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Vendor share-based payments

0

-

-

-

0

-

-

-

121

135

278

133

154

180

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative liability

-

-

-

-

-

-

-

-

-

-

-

-

-

2,125

1,366

-219

-1,989

-2,125

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on issuance of hybrid debt instrument

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on issuance of hybrid debt instrument

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,690

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of subsidiaries

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,069

0

0

0

-

-

-

-

-

-

-

-

-

Fee paid on disposal of subsidiaries

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

430

0

0

0

-

-

-

-

-

-

-

-

-

Foreign currency translation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

353

0

0

0

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

-

-

-

-

-

-

-

-

-

-3,000

5,957

6,000

6,000

3,000

0

0

0

-

-

-

-

-

-

-

-

116

77

43

-7

-124

-99

0

0

0

Prepaid expenses and other assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-136

24

0

0

0

-

-

-

-

-

-

-

-

-

Prepaid expenses and other assets

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable, accrued expenses and other liabilities

-511

-227

334

726

236

-343

-846

-457

-269

-8

-1,801

-1,380

-813

-1,018

1,355

679

614

943

1,292

1,686

543

-479

0

0

0

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,205

-5,039

-5,300

-6,849

-7,577

-10,595

-12,683

0

0

0

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

79

239

17

53

205

183

0

0

0

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15

12

12

12

12

13

0

0

0

Net cash used in operating activities

-6,145

-6,399

-5,762

-5,014

-6,051

-6,463

-584

-553

-453

1,494

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

107

280

29

-1

-11

-12

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment

-

-

-

-

-

-

-

-

-

9

11

11

7

16

14

14

16

1

13

19

40

57

0

0

0

-

-

-

-

-

-

-

-

-

Proceeds from sale of property and equipment

0

2

2

24

24

22

0

0

0

-

-

-

-

-

-

-

-

7

6

6

6

5

0

0

0

-

-

-

-

-

-

-

-

-

Cash acquired from acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

43

0

0

0

-

-

-

-

-

-

-

-

-

Cash transferred in connection with Hive Out Agreement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

43

0

0

0

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-12

-14

6

-7

-13

-34

-52

0

0

0

-

-

-

-

-

-

-

-

-

Net cash provided by investing activities

0

2

2

24

24

22

22

0

-3

-9

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

4,500

4,500

6,500

6,600

3,100

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of promissory note

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

160

0

0

0

0

-

-

-

-

Proceeds from issuance of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,000

0

0

0

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

101

0

0

0

-

-

-

-

-

-

-

-

-

Payments on loan from related party

-

-

-

-

-

-

-

-

-

-

-

-

-

380

142

242

237

0

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,157

6,262

3,000

3,000

-186

-286

9,815

0

0

0

-

-

-

-

-

-

-

-

-

Net proceeds from issuance of common stock and warrants

10,722

13,421

13,421

1,219

2,699

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

13,428

16,127

16,126

2,699

4,179

1,480

1,480

1,480

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

160

0

0

0

0

-

-

-

-

Net change in cash and restricted cash

7,282

9,729

10,365

-2,290

-1,848

-4,961

917

926

-457

1,484

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Effect of exchange rate change on cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-80

268

464

994

587

0

0

0

-

-

-

-

-

-

-

-

-

Net change in cash, excluding restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

3,915

-1,034

-60

669

-2,375

-3,588

-7,312

-9,921

-2,332

-17

2,752

6,013

8

21

29

33

23

22

0

0

0

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest

0

0

0

-0

-0

0

0

1

2

1

0

0

0

-

-

-

-

-

-

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Right of use assets obtained in exchange for lease liability

0

43

43

43

43

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock from cashless exercise of purchase warrants

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of Series B preferred stock to common stock

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest paid in common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

303

303

146

75

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of warrants in connection with debt

-

-

-

-

-

-

-

-

-

-

-

-

-

2,107

3,734

3,327

3,327

1,626

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Recording of derivative liability in connection with debt

-

-

-

-

-

-

-

-

-

-

-

-

-

4,120

5,539

4,765

4,765

1,419

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification of common shares issuable to accounts payable

-

-

-

-

-

-

-

-

-

65

65

65

65

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock for promissory note converted in 2016

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equity consideration transferred in the acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,750

0

0

0

-

-

-

-

-

-

-

-

-

Repurchase and cancellation of common stock in disposal of subsidiaries

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,750

0

0

0

-

-

-

-

-

-

-

-

-

Cash paid for taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0